| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |